Streetbeat News

Stock Prices

HIVE

HC Wainwright & Co. analyst Mike Colonnese downgraded HIVE Digital Technologies (NASDAQ:HIVE) from Buy to Neutral and reduced the price target from $7 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:11 pm

FREY

LICY

NOTE

The article highlights three oversold industrial stocks with RSI values near or below 30, suggesting potential for short-term growth. Li-Cycle Holdings Corp. (LICY) is exploring strategic alternatives and conserving cash. FREYR Battery (FREY) reported a narrower quarterly loss and is focusing on financial strength. FiscalNote Holdings, Inc. (NOTE) achieved Adjusted EBITDA profitability ahead of schedule but reported worse-than-expected revenue.

Portfolio Pulse from Lisa Levin

November 20, 2023 | 12:11 pm

ARM

BABA

SFTBF

SFTBY

Moody's has upgraded SoftBank Group Corp's outlook to stable from negative, affirming its Ba3 Corporate Family rating. The upgrade reflects improved credit fundamentals due to lower leverage and increased transparency after the IPO of Arm Holdings Plc. SoftBank's market value-based leverage improved, and the share of listed assets, including Arm, SoftBank Corp, and Alibaba Group, in its portfolio has risen above 60%. Despite this, SoftBank Group criticized Moody's for maintaining an unsolicited rating. ARM's stock saw a 1.02% increase in premarket trading.

Portfolio Pulse from Anusuya Lahiri

November 20, 2023 | 12:09 pm

SSRM

B of A Securities analyst Michael Jalonen has downgraded SSR Mining (NASDAQ:SSRM) from Buy to Underperform and reduced the price target from $17 to $12.5.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:08 pm

BMY

TSVT

The FDA's Oncologic Drugs Advisory Committee (ODAC) is set to review a supplemental marketing application for Abecma, a therapy developed by Bristol Myers Squibb and 2Seventy Bio, for use in earlier lines of treatment for triple-class exposed relapsed or refractory multiple myeloma. The exact date for the ODAC meeting is not confirmed, and the FDA has indicated that a decision on the application will not be reached by the original PDUFA target date of December 16, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:06 pm

GTEC

Greenland Technologies (NASDAQ:GTEC) reported Q3 losses of $(0.07) per share, significantly missing the $0.05 per share estimate. Sales were $21.84M, also below the expected $24.26M. Compared to last year, earnings decreased by 170%, while sales saw a marginal increase of 0.23%.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:05 pm

GTEC

Greenland Technologies (NASDAQ:GTEC) reported Q3 earnings with an EPS of $-0.07, missing estimates by 240% against an expected $0.05. Revenue increased by $50 thousand year-over-year. Previously, GTEC beat Q2 EPS estimates but saw a 1.17% share price drop the following day. Historical earnings and revenue figures were provided for comparison.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:05 pm

ELBM

HC Wainwright & Co. analyst Heiko Ihle has maintained a Buy rating on Electra Battery Materials (NASDAQ:ELBM) but has reduced the price target from $2.5 to $1.6.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:04 pm

NRG

NRG Energy, Inc. has appointed its Chair, Lawrence Coben, as the Interim President and CEO following the departure of Mauricio Gutierrez from the company.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:03 pm

IMGN

Analysts have recently updated their ratings for Immunogen (NASDAQ:IMGN), with 6 analysts offering an average price target of $22.5, which is 39.32% higher than the current price of $16.15. The new average target represents an 8.85% increase from the previous target of $20.67. Over the past quarter, there have been 3 bullish, 1 somewhat bullish, and 2 indifferent ratings, with no bearish sentiments. Analysts typically review stocks quarterly or after major company events, basing their ratings on financial predictions and company performance.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm